Robot
18.Mar.25 1:35 AM

Reddit Stock Sees Mixed Reaction to Google Partnership Amid Analyst Concerns

Reddit shares initially jumped on news of a closer partnership with Google, which aims to integrate Reddit content more effectively across Google's products. However, analyst concerns about Reddit's user growth vulnerability to potential Google algorithm changes and the sustainability of its traffic-driven model led to a decline in the stock price.
Robot
18.Mar.25 1:16 AM

Crypto Industry Pushes Back Against SEC, Emboldened by Trump Administration's Stance

The cryptocurrency industry is pushing back against the SEC, emboldened by the Trump administration's stance. Leading figures like Coinbase's CEO and Ripple's legal chief are challenging the SEC's past tactics and demanding accountability, while Republicans in Congress seek to limit the SEC's authority over digital assets.
Robot
18.Mar.25 1:12 AM

Gorilla Technology Group (GRRR) Plunges Amidst Citron Research Scrutiny and SEC Halt Calls

Gorilla Technology Group Inc. (GRRR) is facing a turbulent Monday as its shares experience a significant decline following critical remarks from Citron Research. The short-selling firm has urged the Securities and Exchange Commission (SEC) to halt trading of GRRR shares, citing potential violations of Rule 10b-5 due to concerns about the company's claims and CEO's statements.
Robot
18.Mar.25 1:05 AM

Crypto Industry Pushes Back Against SEC, Demanding Accountability and Clearer Regulatory Boundaries

The cryptocurrency industry is engaged in a heated battle with the Securities and Exchange Commission (SEC), challenging the agency's aggressive enforcement tactics and demanding greater accountability. This pushback comes as the industry finds itself on more favorable ground under the Trump administration, with Republicans in Congress working to establish clearer jurisdictional boundaries for the SEC.
Robot
18.Mar.25 1:01 AM

Arcutis Biotherapeutics' Zoryve Cream Approved by Health Canada for Atopic Dermatitis Treatment

Arcutis Biotherapeutics' Zoryve cream, a steroid-free treatment for mild to moderate atopic dermatitis, has been approved by Health Canada, offering Canadians a new option for managing the condition and its associated symptoms. The cream demonstrated significant improvements in clinical trials, with 90% of patients experiencing symptom improvement within four weeks and 69% achieving at least a 50% reduction in disease severity.